New Delhi [India], October 17 (ANI): The interim analysis of WHO's Solidarity Trial has revealed that 4 repurposed drugs for COVID-19--remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens-- appeared to have little or no effect on reducing mortality, initiation of venti
New Delhi [India], October 16 (ANI): The interim analysis of World Health Organisation (WHO)'s Solidarity Trial has revealed that four repurposed drugs for COVID-19--remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on reducing m